FKFleur Kilburn-Toppin

Fleur Kilburn-Toppin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fleur Kilburn-Toppin has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Does pre-operative breast MRI have an impact on surgical outcomes in high-grade DCIS?

    by Nuala A. Healy, Yethiksha Parag, Giorgia Soppelsa, Primee Wignarajah, John R. Benson, Amit Agrawal, Parto Forouhi, Fleur Kilburn-Toppin, Fiona J. Gilbert

    Objectives: High-grade DCIS (HG DCIS) is associated with upgrade to invasive disease but few studies evaluate the role of MRI in this subset of DCIS. This study compared surgical outcomes of females with HG DCIS on biopsy who had pre-operative MRI with those that proceeded directly to surgery. Methods: This single-centre retrospective, observational study identified patients with pure HG DCIS on pre-operative biopsy from the pathology database. Surgical outcomes, clinicopathological and radiological features were obtained for all patients. Results: From August 2015 to February 2020, 217 patients had HG DCIS on biopsy. Pre-operative MRI was performed in 40 (MRI group) and not in 88 (No MRI group) patients. Initial mastectomy was performed in 25/40 (63%) women in the MRI group and 20/88 (23%) women in the no MRI group (p < 0.0001). No difference was observed in re-operation rate between the two groups, 15% in MRI group vs 22% in No MRI group (p = 0.4749). Mean tumour size on histology was larger in mastectomy cases in the MRI group (73.4 mm, range 6–140 mm), than the total MRI group, (58.3 mm, range 0–140 mm) or no MRI group (30.7 mm, range 0–130 mm) (p < 0.0001). Conclusions: Pre-operative MRI in HG DCIS is associated with higher mastectomy rates, possibly due to patient selection for MRI, as tumours on final histology were significantly larger. Fewer re-operations were observed in the MRI group although this was not significant. Advances in knowledge: Breast MRI performed pre-operatively in HG DCIS is associated with higher mastectomy rates and fewer re-operation rates.


  • Open Access

    Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging

    by With Language Review By Europa Donna–The European Breast Cancer Coalition For The European Society Of Breast Imaging (Eusobi), Ulrich Bick, Rubina M. Trimboli, Alexandra Athanasiou, Corinne Balleyguier, Pascal A. T. Baltzer, Maria Bernathova, Krisztina Borbély, Boris Brkljacic, Luca A. Carbonaro, et al.

    We summarise here the information to be provided to women and referring physicians about percutaneous breast biopsy and lesion localisation under imaging guidance. After explaining why a preoperative diagnosis with a percutaneous biopsy is preferred to surgical biopsy, we illustrate the criteria used by radiologists for choosing the most appropriate combination of device type for sampling and imaging technique for guidance. Then, we describe the commonly used devices, from fine-needle sampling to tissue biopsy with larger needles, namely core needle biopsy and vacuum-assisted biopsy, and how mammography, digital breast tomosynthesis, ultrasound, or magnetic resonance imaging work for targeting the lesion for sampling or localisation. The differences among the techniques available for localisation (carbon marking, metallic wire, radiotracer injection, radioactive seed, and magnetic seed localisation) are illustrated. Type and rate of possible complications are described and the issue of concomitant antiplatelet or anticoagulant therapy is also addressed. The importance of pathological-radiological correlation is highlighted: when evaluating the results of any needle sampling, the radiologist must check the concordance between the cytology/pathology report of the sample and the radiological appearance of the biopsied lesion. We recommend that special attention is paid to a proper and tactful approach when communicating to the woman the need for tissue sampling as well as the possibility of cancer diagnosis, repeat tissue sampling, and or even surgery when tissue sampling shows a lesion with uncertain malignant potential (also referred to as “high-risk” or B3 lesions). Finally, seven frequently asked questions are answered.


  • MRI-guided breast biopsy: a review of technique, indications, and radiological–pathological correlations

    by V. Papalouka, F. Kilburn-Toppin, M. Gaskarth, F. Gilbert